AI-picked stocks now up 150%+; an 111% outperformance vs. the S&P 500
Investing.com -- Visionary Education Technology Holdings Group Inc (NASDAQ:GV) stock surged 76.4% Wednesday after the company announced a strategic partnership with Jiangsu Yike Regenerative Medicine, a leading Chinese regenerative medical research institute.
The technology-driven multinational enterprise will collaborate with Yike on research, development, and commercialization in cellular rejuvenation and aesthetic treatment. This partnership marks GV’s strategic entry into the Consumption Healthcare sector, specifically targeting the Medical Aesthetics industry.
Under the agreement, Yike will lead and fund the research and development efforts, while GV may later acquire or license the intellectual property rights through cash or share-based transactions. The partnership will focus on cell activation and telomerase homeostasis, smart delivery systems with personalized solutions, and stem cell applications.
The collaboration will leverage Yike’s proprietary technologies, including its Cell-Activating Complex, Nano-Delivery ultra-permeable liposomal technology, and AI-based Aging Assessment Model. GV will work closely with Dr. Zhenyu Ju, Yike’s Chief Scientist and Dean of the Institute of Aging and Regenerative Medicine at Jinan University.
Dr. Ju, a recipient of China’s National Science Fund for Distinguished Young Scholars, stated: "We are very pleased to collaborate with GV, a company with strong international marking experience and global vision. GV’s global resources and commercialization experience are highly complementary to Yike’s research into aging interventions. This partnership will accelerate the translation of fundamental research into clinical applications, delivering safer and more effective anti-aging solutions to consumers in China and worldwide."
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.